Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing

AC Chrysostomou, DC Stylianou, A Constantinidou… - Viruses, 2018 - mdpi.com
Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

[HTML][HTML] Commercially available molecular tests for human papillomaviruses: a global overview

M Poljak, AO Valenčak, GG Domjanič, L Xu… - Clinical Microbiology and …, 2020 - Elsevier
Background Molecular tests for detection of human papillomaviruses (HPVs) play a crucial
role in the prevention of cervical cancer, including recently announced elimination efforts …

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older …

PE Castle, MH Stoler, TC Wright, A Sharma… - The lancet …, 2011 - thelancet.com
Background The ATHENA study was designed to assess the performance of carcinogenic
human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping compared with liquid …

Commercially available molecular tests for human papillomaviruses (HPV): 2015 update

M Poljak, BJ Kocjan, A Oštrbenk, K Seme - Journal of Clinical Virology, 2016 - Elsevier
Commercial molecular tests for human papillomaviruses (HPV) are invaluable diagnostic
tools in cervical carcinoma screening and management of women with cervical …

Reproductive health screening disparities and sexual orientation in a cohort study of US adolescent and young adult females

BM Charlton, HL Corliss, SA Missmer, AL Frazier… - Journal of Adolescent …, 2011 - Elsevier
PURPOSE: To examine sexual orientation group disparities in the Papanicolaou (Pap) and
sexually transmitted infection (STI)/human papillomavirus (HPV) tests among adolescents …

Nucleic acid tests for the detection of alpha human papillomaviruses

M Poljak, J Cuzick, BJ Kocjan, T Iftner, J Dillner… - Vaccine, 2012 - Elsevier
Testing for high-risk types of alpha human papillomaviruses (HPV) is an invaluable part of
clinical guidelines for cervical carcinoma screening, management and treatment. In this …

Commercially available assays for multiplex detection of alpha human papillomaviruses

M Poljak, BJ Kocjan - Expert review of anti-infective therapy, 2010 - Taylor & Francis
Five main groups of commercial assays for the multiplex detection of alpha human
papillomaviruses (HPVs) are currently available. DNA-based screening assays, which test …

Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS

Y Zhu, C Ren, L Yang, X Zhang, L Liu, Z Wang - BMC cancer, 2019 - Springer
Background Atypical squamous cell of undetermined significance (ASCUS) is a common
cervical cytological diagnosis. At present, HPV DNA assay is used to triage these patients …

Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA

G Coquillard, B Palao, BK Patterson - Gynecologic oncology, 2011 - Elsevier
OBJECTIVES: Current methods for HPV screening rely on the detection of L1 DNA from high
risk genotypes (HRHPV). These assays have very high negative predictive values (~ 99%) …

[HTML][HTML] Molecular methods and platforms for infectious diseases testing: A review of FDA-approved and cleared assays

R Emmadi, JB Boonyaratanakornkit… - The Journal of Molecular …, 2011 - Elsevier
The superior sensitivity and specificity associated with the use of molecular assays has
greatly improved the field of infectious disease diagnostics by providing clinicians with …